Health Canada: potential risk with unauthorised cell therapies

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1755卷 / 1期

关键词：

D O I：

10.1007/s40278-019-62555-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：1 / 1

相关论文

共 50 条

[31] Health Canada: no risk of tendon disorders with imatinib
Reactions Weekly, 2018, 1707 (1) : 2 - 2
[32] Health Canada: risk of VTE with tofacitinib and ruxolitinib
Reactions Weekly, 2020, 1811 (1) : 3 - 3
[33] Health Canada: thiamazole linked with risk of vasculitis
Reactions Weekly, 2020, 1802 (1) : 3 - 3
[34] Sentimentalising a potential health risk
K J Cottingham
British Dental Journal, 1998, 185 : 110 - 110
[35] Sentimentalising a potential health risk
Cottingham, KJ
BRITISH DENTAL JOURNAL, 1998, 185 (03) : 110 - 110
[36] Vascular injury and repair: a potential target for cell therapies
Mitchell, Andrew
Fujisawa, Takeshi
Newby, David
Mills, Nicholas
Cruden, Nicholas L.
FUTURE CARDIOLOGY, 2015, 11 (01) : 45 - 60
[37] Realizing the Potential of CAR-T Cell Therapies
Challener, Cynthia A.
BIOPHARM INTERNATIONAL, 2016, 29 (05) : 13 - 19
[38] Can Cell and Gene Therapies Achieve Their Full Potential?
Shanley, Agnes
BIOPHARM INTERNATIONAL, 2021, 34 (01) : 41 - 43
[39] Gene and Cell Therapies for Diabetes MellitusStrategies and Clinical Potential
Nick Giannoukakis
Paul D. Robbins
BioDrugs, 2002, 16 : 149 - 173
[40] Mesenchymal stromal cell therapies: potential and pitfalls for ARDS
Masterson, C.
Jerkic, M.
Curley, G. F.
Laffey, J. G.
MINERVA ANESTESIOLOGICA, 2015, 81 (02) : 179 - 194

← 1 2 3 4 5 →